Cyclerion Therapeutics, Inc. Research And Development Expense

• Cyclerion Therapeutics, Inc. showed an increase of +235.3% in Research And Development Expense from 2024 to 2025.
• This data is from Cyclerion Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), Cyclerion Therapeutics, Inc.'s Research And Development Expense has declined by 98.9%.
• Historical annual values: Fiscal year 2025: $959.0 thousand | Fiscal year 2024: $286.0 thousand | Fiscal year 2023: $1.52 million | Fiscal year 2022: $5.98 million | Fiscal year 2021: $37.64 million | Fiscal year 2020: $56.41 million | Fiscal year 2019: $95.14 million | Fiscal year 2018: $87.72 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026